206 related articles for article (PubMed ID: 30558595)
1. State variation in opioid treatment policies and opioid-related hospital readmissions.
Blanchard J; Weiss AJ; Barrett ML; McDermott KW; Heslin KC
BMC Health Serv Res; 2018 Dec; 18(1):971. PubMed ID: 30558595
[TBL] [Abstract][Full Text] [Related]
2. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
[TBL] [Abstract][Full Text] [Related]
3. Readmissions Following Inpatient Treatment for Opioid-Related Conditions.
Blanchard J; Weiss AJ; Barrett ML; Stocks C; Owens PL; Coffey R; Heslin KC
Subst Use Misuse; 2019; 54(3):473-481. PubMed ID: 30618327
[TBL] [Abstract][Full Text] [Related]
4. Relationship between insurance and 30-day readmission rates in patients 65 years and older discharged from an acute care hospital with hospice services.
Whitney P; Chuang EJ
J Hosp Med; 2016 Oct; 11(10):688-693. PubMed ID: 27222206
[TBL] [Abstract][Full Text] [Related]
5. Coronary artery bypass graft readmission rates and risk factors - A retrospective cohort study.
Feng TR; White RS; Gaber-Baylis LK; Turnbull ZA; Rong LQ
Int J Surg; 2018 Jun; 54(Pt A):7-17. PubMed ID: 29678620
[TBL] [Abstract][Full Text] [Related]
6. U.S. National 90-Day Readmissions After Opioid Overdose Discharge.
Peterson C; Liu Y; Xu L; Nataraj N; Zhang K; Mikosz CA
Am J Prev Med; 2019 Jun; 56(6):875-881. PubMed ID: 31003811
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Naloxone Access Laws on Fatal Synthetic Opioid Overdose Fatality Rates.
Tabatabai M; Cooper RL; Wilus DM; Edgerton RD; Ramesh A; MacMaster SA; Patel PN; Singh KP
J Prim Care Community Health; 2023; 14():21501319221147246. PubMed ID: 36625264
[TBL] [Abstract][Full Text] [Related]
8. Trends in Readmission Rates, Hospital Charges, and Mortality for Patients With Chronic Obstructive Pulmonary Disease (COPD) in Florida From 2009 to 2014.
Jiang X; Xiao H; Segal R; Mobley WC; Park H
Clin Ther; 2018 Apr; 40(4):613-626.e1. PubMed ID: 29609879
[TBL] [Abstract][Full Text] [Related]
9. Association of Medicaid Expansion With Opioid Overdose Mortality in the United States.
Kravitz-Wirtz N; Davis CS; Ponicki WR; Rivera-Aguirre A; Marshall BDL; Martins SS; Cerdá M
JAMA Netw Open; 2020 Jan; 3(1):e1919066. PubMed ID: 31922561
[TBL] [Abstract][Full Text] [Related]
10. Reducing Behavioral Health Inpatient Readmissions for People With Substance Use Disorders: Do Follow-Up Services Matter?
Reif S; Acevedo A; Garnick DW; Fullerton CA
Psychiatr Serv; 2017 Aug; 68(8):810-818. PubMed ID: 28412900
[TBL] [Abstract][Full Text] [Related]
11. Association between state Medicaid expansion status and naloxone prescription dispensing.
Sohn M; Talbert JC; Delcher C; Hankosky ER; Lofwall MR; Freeman PR
Health Serv Res; 2020 Apr; 55(2):239-248. PubMed ID: 32030751
[TBL] [Abstract][Full Text] [Related]
12. Opioid-overdose laws association with opioid use and overdose mortality.
McClellan C; Lambdin BH; Ali MM; Mutter R; Davis CS; Wheeler E; Pemberton M; Kral AH
Addict Behav; 2018 Nov; 86():90-95. PubMed ID: 29610001
[TBL] [Abstract][Full Text] [Related]
13. Thirty-Day Hospital Readmission for Medicaid Enrollees with Schizophrenia: The Role of Local Health Care Systems.
Busch AB; Epstein AM; McGuire TG; Normand SL; Frank RG
J Ment Health Policy Econ; 2015 Sep; 18(3):115-24. PubMed ID: 26474051
[TBL] [Abstract][Full Text] [Related]
14. Patient Readmission Rates For All Insurance Types After Implementation Of The Hospital Readmissions Reduction Program.
Ferro EG; Secemsky EA; Wadhera RK; Choi E; Strom JB; Wasfy JH; Wang Y; Shen C; Yeh RW
Health Aff (Millwood); 2019 Apr; 38(4):585-593. PubMed ID: 30933582
[TBL] [Abstract][Full Text] [Related]
15. Rates and predictors of 30-day readmission among commercially insured and Medicaid-enrolled patients hospitalized with systolic heart failure.
Allen LA; Smoyer Tomic KE; Smith DM; Wilson KL; Agodoa I
Circ Heart Fail; 2012 Nov; 5(6):672-9. PubMed ID: 23072736
[TBL] [Abstract][Full Text] [Related]
16. Short-term rehospitalization across the spectrum of age and insurance types in the United States.
Strom JB; Kramer DB; Wang Y; Shen C; Wasfy JH; Landon BE; Wilker EH; Yeh RW
PLoS One; 2017; 12(7):e0180767. PubMed ID: 28700736
[TBL] [Abstract][Full Text] [Related]
17. Frequency, cost, and risk factors of readmissions among severe sepsis survivors.
Goodwin AJ; Rice DA; Simpson KN; Ford DW
Crit Care Med; 2015 Apr; 43(4):738-46. PubMed ID: 25746745
[TBL] [Abstract][Full Text] [Related]
18. Impact of Critical Illness on Resource Utilization: A Comparison of Use in the Year Before and After ICU Admission.
Hirshberg EL; Wilson EL; Stanfield V; Kuttler KG; Majercik S; Beesley SJ; Orme J; Hopkins RO; Brown SM
Crit Care Med; 2019 Nov; 47(11):1497-1504. PubMed ID: 31517693
[TBL] [Abstract][Full Text] [Related]
19. Prescription opioid use patterns, use disorder diagnoses and addiction treatment receipt after the 2014 Medicaid expansion in Oregon.
Springer R; Marino M; Bailey SR; Angier H; O'Malley JP; Hoopes M; Lindner S; DeVoe JE; Huguet N
Addiction; 2019 Oct; 114(10):1775-1784. PubMed ID: 31106483
[TBL] [Abstract][Full Text] [Related]
20. Discharge locations after hospitalizations involving opioid use disorder among medicare beneficiaries.
Moyo P; Eliot M; Shah A; Goodyear K; Jutkowitz E; Thomas K; Zullo AR
Addict Sci Clin Pract; 2022 Oct; 17(1):57. PubMed ID: 36209151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
